mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
5e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0001 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.23 |
0.0003 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.0003 |
mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.0003 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0003 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.0004 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0005 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0009 |